Warby Parker slashes sales outlook for the year as loss widens

Warby Parker slashes sales outlook for the year as loss widens


A general view of the atmosphere at Warby Parker’s store in The Standard, Hollywood

Michael Buckner | Warby Parker | Getty Images

Warby Parker on Thursday joined the slew of retailers that have cut their financial forecasts for the year, even as it reported a narrower-than-expected loss in its fiscal second quarter and sales in-line with analysts’ estimates.

Chief Financial Officer Steve Miller said the eye glasses maker is facing an “uncertain macroeconomic environment.”

“We are taking a disciplined approach to managing costs to set us up for sustainable growth and profitability,” he said in a statement.

Warby shares rose less than 1% extended trading. As of Wednesday’s market close, the stock had tumbled nearly 70% year to date.

Here’s how Warby did in its fiscal second quarter ended June 30 compared with what analysts were anticipating, based on Refinitiv estimates:

  • Loss per share: 1 cent adjusted vs. 2 cents expected
  • Revenue: $149.6 million vs. $149.5 million expected

Warby’s loss for the three-month period ended June 30 widened to $32.2 million, or 28 cents per share, from a loss of $18.8 million, or 35 cents a share, a year earlier. Excluding one-time items, it lost a penny a share.

Sales grew roughly 14% to $149.6 million from $131.6 million a year earlier, boosted in part by loyal customers spending more money on average.

The company said its count of active customers increased 8.7% to 2.26 million. It defines these customers as people who have made at least one purchase of any product or service from Warby in the previous 12-month period.

For fiscal 2022, Warby is now calling for sales to be within a range of $584 million to $595 million, down from a prior range of $650 million to $660 million.

It sees its adjusted EBITDA amounting to about $22 million to $26 million, including a $7.5 million hit related to pandemic-related disruptions to its business.

This story is developing. Please check back for updates.



Source

FDA withdrew studies finding Covid, shingles vaccines were safe 
Business

FDA withdrew studies finding Covid, shingles vaccines were safe 

The FDA blocked the publication of several studies supporting the safety of vaccines against Covid and shingles in recent months, a Health and Human Services Department spokesperson confirmed on Tuesday.  It’s the latest effort by the Trump administration to challenge safe and effective shots in the U.S. and make them harder to access for some […]

Read More
Spirit starts monthslong process of dismantling airline after biggest collapse in a generation
Business

Spirit starts monthslong process of dismantling airline after biggest collapse in a generation

A Spirit Airlines airplane at Baltimore Washington International Thurgood Marshall Airport (BWI) in Baltimore, Maryland, US, on Saturday, May 2, 2026. Daniel Heuer | Bloomberg | Getty Images Spirit Airlines’ more than three-decade run ended over the weekend, but on Tuesday it was just starting the monthslong process of dismantling the company after the biggest […]

Read More
FDA commissioner defends agency’s drug approval decisions after wave of backlash
Business

FDA commissioner defends agency’s drug approval decisions after wave of backlash

Martin Makary, commissioner of the Food and Drug Administration (FDA), during a news conference at the US Food and Drug Administration headquarters in Silver Spring, Maryland, US, on Tuesday, April 28, 2026. Valerie Plesch | Bloomberg | Getty Images U.S. Food and Drug Administration Commissioner Marty Makary defended himself in a CNBC interview aired Tuesday […]

Read More